Posters
« Back
A Novel Anti-LAG3 Monoclonal Antibody
EP34533
Poster Title: A Novel Anti-LAG3 Monoclonal Antibody
Submitted on 01 Dec 2020
Author(s): Protheragen
Affiliations:
Poster Views: 171
View poster »


Poster Information
Abstract: Anti-LAG3 mAb is a monoclonal antibody targets lymphocyte activating 3 (LAG3) that involves in T cell immune regulation. Anti-LAG3 mAb as an antagonistic antibody removes LAG3 mediated T cell inhibition to make nonspecific immune activation, for the treatment of various solid tumors and hematologic cancers.Summary: Anti-LAG3 mAb differs from the leading competitor (monoclonal antibody 25F7 from Bristol Myers Squibb) with different epitope and higher affinity. Its optimal safety and efficacy can ensure its market share.References: https://www.protheragen.com/available-projects/a-novel-anti-lag3-monoclonal-antibody/Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons
© 2021 Technology Networks Ltd.
Privacy Policy & Disclaimer